Dreilich M - Search Results

1

The role of cystatin C and the angiogenic cytokines VEGF and bFGF in patients with esophageal carcinoma.

Dreilich M, Wagenius G, Bergström S, Brattström D, Larsson A, Hesselius P, Bergqvist M. Dreilich M, et al. Med Oncol. 2005;22(1):29-38. doi: 10.1385/MO:22:1:029. Med Oncol. 2005. PMID: 15750194

2

Newly developed assay measuring cytokeratins 8, 18 and 19 in serum is correlated to survival and tumor volume in patients with esophageal carcinoma.

Brattström D, Wagenius G, Sandström P, Dreilich M, Bergström S, Goike H, Hesselius P, Bergqvist M. Brattström D, et al. Among authors: dreilich m. Dis Esophagus. 2005;18(5):298-303. doi: 10.1111/j.1442-2050.2005.00504.x. Dis Esophagus. 2005. PMID: 16197528

3

HER-2 overexpression (3+) in patients with squamous cell esophageal carcinoma correlates with poorer survival.

Dreilich M, Wanders A, Brattström D, Bergström S, Hesselius P, Wagenius G, Bergqvist M. Dreilich M, et al. Dis Esophagus. 2006;19(4):224-31. doi: 10.1111/j.1442-2050.2006.00570.x. Dis Esophagus. 2006. PMID: 16866851

4

The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.

Bergström S, Dreilich M, Wagenius G, Brattström D, Larsson A, Hesselius P, Bergqvist M. Bergström S, et al. Among authors: dreilich m. In Vivo. 2004 Sep-Oct;18(5):615-20. In Vivo. 2004. PMID: 15523902 Free article.

5

High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study.

Dreilich M, Bergqvist M, Moberg M, Brattström D, Gustavsson I, Bergström S, Wanders A, Hesselius P, Wagenius G, Gyllensten U. Dreilich M, et al. BMC Cancer. 2006 Apr 18;6:94. doi: 10.1186/1471-2407-6-94. BMC Cancer. 2006. PMID: 16620378 Free PMC article.

6

Genes associated with telomerase activity levels in esophageal carcinoma cell lines.

Bergqvist M, Brattström D, Brodin D, Lindkvist A, Dahlman-Wright K, Dreilich M, Wagenius G, Paulsson-Karlsson Y. Bergqvist M, et al. Among authors: dreilich m. Dis Esophagus. 2006;19(1):20-3. doi: 10.1111/j.1442-2050.2006.00532.x. Dis Esophagus. 2006. PMID: 16364039

7

A retrospective study focusing on clinical predictive factors in 126 patients with oesophageal carcinoma.

Dreilich M, Bergström S, Wagenius G, Brattström D, Bergqvist M. Dreilich M, et al. Anticancer Res. 2004 May-Jun;24(3b):1915-20. Anticancer Res. 2004. PMID: 15274376 Free article.

8

Telomerase activity is not a key determinant of sensitivity to standard cytotoxic drugs in human esophageal carcinoma cell lines.

Dreilich M, Lindkvist A, Dhar S, Paulsson-Karlsson Y, Brattström D, Nygren P, Rickardson L, Wagenius G, Bergqvist M. Dreilich M, et al. Anticancer Drugs. 2006 Jun;17(5):503-9. doi: 10.1097/00001813-200606000-00003. Anticancer Drugs. 2006. PMID: 16702806

9

Esophageal cancer: current and emerging therapy modalities.

Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, Bergqvist M. Ekman S, et al. Among authors: dreilich m. Expert Rev Anticancer Ther. 2008 Sep;8(9):1433-48. doi: 10.1586/14737140.8.9.1433. Expert Rev Anticancer Ther. 2008. PMID: 18759695 Review.

10

Health status and health care utilization after discharge from geriatric in-hospital stay - description of a register-based study.

Rydwik E, Lindqvist R, Willers C, Carlsson L, Nilsson GH, Lager A, Dreilich M, Lindh Mazya A, Karlsson T, Alinaghizadeh H, Boström AM. Rydwik E, et al. Among authors: dreilich m. BMC Health Serv Res. 2021 Jul 31;21(1):760. doi: 10.1186/s12913-021-06751-3. BMC Health Serv Res. 2021. PMID: 34332571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters